Reishi Mushroom

Ganoderma lucidum
Evidence Level
Moderate
2 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

Reishi mushroom, known as the 'mushroom of immortality' in Traditional Chinese Medicine, has been used for over 2,000 years for immune support and longevity. Its primary bioactive compounds — triterpenoids and beta-glucans — have demonstrated immunomodulatory, antioxidant, and adaptogenic effects in clinical research.

Studied Dose 1.5–9 g/day whole mushroom powder; 1–1.5 g/day standardized extract
Active Compound Beta-glucans (≥30%) and Triterpenoids (ganoderic acids) — fruiting body extract

Immune modulation

Beta-glucans from reishi activate macrophages, NK cells, and dendritic cells. Studies show increases in NK cell activity and cytokine production, supporting immune surveillance.

Stress adaptation and sleep

Triterpenoids modulate the HPA axis and have GABA-like effects on the CNS, improving sleep quality and reducing anxiety. Reishi is one of the most used adaptogens in TCM for nervous system support.

Antioxidant protection

Rich in polyphenols and triterpenoids that scavenge reactive oxygen species and upregulate endogenous antioxidant enzymes (SOD, catalase, GPx), protecting cells from oxidative damage.

Cardiovascular support

Ganoderic acids inhibit cholesterol synthesis and platelet aggregation. Studies show modest reductions in blood pressure and LDL cholesterol with long-term supplementation.

1

Beta-glucan receptor activation

Reishi beta-glucans bind to Dectin-1 receptors and TLR-2 on innate immune cells, activating NF-κB signaling and triggering production of pro-inflammatory cytokines, NK cell activation, and enhanced phagocytosis.

2

Triterpenoid adaptogenic activity

Ganoderic acids modulate cortisol secretion, inhibit inflammatory enzymes (COX-1/2), and interact with GABA-A receptors to produce calming and sleep-promoting effects.

3

HMG-CoA reductase inhibition

Certain ganoderic acids inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis — same target as statin drugs — contributing to the observed lipid-lowering effects.

1
Reishi Mushroom and Immune Function in Advanced Cancer Patients
PubMed

RCT of reishi polysaccharide extract vs. placebo in 48 patients with advanced colorectal cancer over 12 weeks.

48 advanced colorectal cancer patients. 12-week intervention.

Significant increases in NK cell and lymphocyte counts, improved CD4+/CD8+ ratio, and higher IL-2, IL-6, and IFN-γ levels vs. placebo.

2
Ganoderma lucidum and Quality of Life in Breast Cancer Patients
PubMed

RCT examining reishi extract supplementation in breast cancer patients undergoing endocrine therapy.

48 breast cancer patients. 4-week intervention.

Significant improvements in fatigue, anxiety, and overall quality of life scores. Reishi group showed higher NK cell activity vs. placebo. Well-tolerated.

Common Potential side effects

GI upset, dry mouth, dizziness in some users especially at higher doses
Mild liver enzyme elevation reported with long-term use of concentrated extracts — monitor
Potential allergic reactions in mushroom-sensitive individuals

Important Drug interactions

Anticoagulants (warfarin) — reishi inhibits platelet aggregation; increased bleeding risk
Antihypertensives — additive blood pressure-lowering effect
Immunosuppressants — reishi stimulates immune function; may counteract cyclosporine